| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.54 | 0.02 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.42 | 0.07 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.0005 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.25 | 0.3 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.21 | 0.4 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.2 | 0.009 |